Markers in the blood can predict how multiple sclerosis will develop and what drugs will be ­effective, a study found.

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

aDementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK bDepartment of Clinical and Movement Neurosciences, Queen Square Brain Bank for Neurological ...

Villegas’ and Rodrigeuz-Hernandez’ stories are all too common in California, where the average cost of health care is the third highest in the nation. Maria Martinez-Aguilar was accused of assaulting ...

This article examines how next-generation sequencing and state-of-the-art imaging technologies are being combined to ...

Multiple sclerosis (MS) is a disease that looks different in everyone who has it ... In 2018, the center opened a state-of-the-art infusion suite equipped with 15 infusion chairs in private and ...

Using geochemistry, scientists have identified a new blood biomarker that could help diagnose Alzheimer’s disease sooner, ...

Drug development companies are working to increase the chances of clinical success by improving biomarker identification, validation, and analysis.

NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people. Looking back over the journey from our humble beginnings ...

Days after Sanofi reported back-to-back failures for its BTK inhibitor, Roche’s fenebrutinib on Wednesday scored a mid-stage win in relapsing multiple sclerosis, demonstrating near-total elimination ...

“People who need everything - in addition to the polio vaccinations, medical supplies, hygiene products and clean water are absolutely critical to stop the spread of disease,” Ms. Wateridge insisted. ...